2023
DOI: 10.1017/gmh.2023.9
|View full text |Cite
|
Sign up to set email alerts
|

Facilitators and barriers to implementation of suicide prevention interventions: Scoping review

Abstract: We know that suicide is preventable, yet hundreds of thousands of people still die due to suicide every year. Many interventions were proven to be effective, and dozens of others showed promising results. However, translating these interventions into new settings brings several challenges. One of the crucial obstacles to success is not anticipating possible barriers to implementation nor enhancing possible benefits of factors facilitating the implementation. While we witnessed great support for suicide prevent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 87 publications
0
8
0
Order By: Relevance
“…Funding agencies may wish to encourage the incorporation of Type I hybrid study procedures (e.g., qualitative inquiry on barriers and facilitators post-implementation of interventions) to ensure research studies collect sufficient information regarding implementation processes to increase future adoption and uptake of findings. Additionally, past literature has highlighted tailoring to patient needs as a key facilitator in the implementation of suicide prevention interventions [ 8 ]. However, outcomes involving feedback from patients were the least common in our sample.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Funding agencies may wish to encourage the incorporation of Type I hybrid study procedures (e.g., qualitative inquiry on barriers and facilitators post-implementation of interventions) to ensure research studies collect sufficient information regarding implementation processes to increase future adoption and uptake of findings. Additionally, past literature has highlighted tailoring to patient needs as a key facilitator in the implementation of suicide prevention interventions [ 8 ]. However, outcomes involving feedback from patients were the least common in our sample.…”
Section: Discussionmentioning
confidence: 99%
“…However, there remains limited adoption of these interventions as well as significant variability in effectiveness, which may be secondary to implementation challenges. A recent review identifies several implementation barriers that impact suicide prevention programming, including but not limited to high levels of complexity and cost as well as insufficient tailoring to patient needs [ 8 ]. It is, however, unknown which implementation strategies may be most helpful for addressing these needs to enhance the reach and effectiveness of promising suicide prevention programming.…”
Section: Introductionmentioning
confidence: 99%
“…Although adverse effects have been reported [ 25 ], evaluation studies rarely explicitly assess unwanted side effects (USE) and serious adverse events (SAE) [ 11 ] raising doubts about the safety of prevention programs. Ultimately, the implementation of evidence-based programs is hindered by significant practical barriers, such as low acceptability and high costs [ 12 , 26 ]. Accessible and acceptable interventions with a solid empiric foundation are urgently needed and should be evaluated in high-quality trials with adequate outcomes considering both positive and negative effects [ 11 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Although adverse effects have been reported [23], evaluation studies rarely explicitly assess unwanted side effects (USE) and serious adverse events (SAE) [10] raising doubts about the safety of prevention programs. Ultimately, the implementation of evidence-based programs is hindered by signi cant practical barriers, such as low acceptability and high costs [11,24]. Accessible and acceptable interventions with a solid empiric foundation are urgently needed and should be evaluated in high-quality trials with adequate outcomes considering both positive and negative effects [10,20].…”
Section: Introductionmentioning
confidence: 99%